Surrey Heartlands

Joint Formulary & PAD

Menotrophin - Male hypogonadism

You are here : Home > Formulary Search > Menotrophin - Male hypogonadism

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
R
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Menotrophin
Indication :
Male hypogonadism
Group Name :
Keywords :
Hypogonadotrophic hypogonadism, gonadotrophin replacement therapy
Brand Names Include :
Meriofert, Menopur
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Menotrophin is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Male hypogonadism.

Committee Recommendations (1)

11 Feb 25 - Surrey Heartlands Medicines Optimisation Board (MOB)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.